Weight-Loss Injections May Slash Cancer Risk
A pivotal new study presented at the European Congress on Obesity in Malaga, Spain, suggests that widely used weight-loss injections, known as GLP-1 receptor agonists (GLP-1RAs), could dramatically reduce the risk of obesity-related cancers by almost 50%. This groundbreaking finding has led cancer experts to declare the potential advent of…
